Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
period may be extended for maternity and parental leave, long-term illness (more than 90 days), care for a family member (more than 90 days), pre-attestation preparation, or military service. At least one
-
of dissertation defence). This period may be extended for maternity and parental leave, long-term illness (more than 90 days), care for a family member (more than 90 days), pre-attestation preparation, or military
-
Department: Nanobiotechnology Core Facility – Central European Institute of Technology Deadline: 31 Jul 2025 Start date: September - December 2025 (to be negotiated) Job type: full-time Job field
-
be assessed, focusing on lipid-induced modulation of enzymatic activity in two bacterial proteins: OmpLA, a β-barrel protein, and GlpG, an α-helical transmembrane protein. The findings will offer key
-
peptides, including the design of de novo sequences based on the elucidated mechanism. The first step will be to develop a computational approach to determine the critical peptide properties required
-
an open PhD student position in Robert Vacha's Research Group! With nearly 10 million lives claimed annually, cancer remains one of the leading causes of mortality worldwide, highlighting the urgent need
-
will have a PhD in hand by the start date (July 1st) or shortly thereafter. It is necessary that within the last 5 years, the candidate held at least a 0.5 academic position outside Czechia for at least
-
Ph.D. in linguistics or a related field. In the ideal case, the candidate will have a PhD in hand by the start date (July 1st) or shortly thereafter. It is necessary that within the last 5 years
-
level 8) no more than 7 years ago (from the date of dissertation defense). This period may be extended for maternity or parental leave, long-term illness (more than 90 days), caregiving for a family
-
interactions will be assessed, focusing on lipid-induced modulation of enzymatic activity in two bacterial proteins: OmpLA, a β-barrel protein, and GlpG, an α-helical transmembrane protein. The findings will